Table 4.

Inflammation markers (median and 25–75 percentiles) at baseline and after 40 weeks in participants treated with Liraglutide or placebo

	Liraglutide (n = 17)			Placebo (n = 13)
Variables	Baseline	40 weeks	p-value	Baseline	40 weeks	p-value
CRP (mg/L)	3.69 (2.83–5.24)	2.39 (1.69–4.47)	0.080	4.37 (2.42–6.91)	3.22 (1.79–8.30)	0.600
IL-6 (pg/mL)	5.05 (3.21–6.56)	4.03 (2.77–5.84)	0.278	4.38 (3.26–8.71)	4.81 (2.76–6.62)	0.347
MCP-1 (pg/mL)	281 (203–329)	283 (210–327)	0.586	306 (223–350)	274 (246–345)	0.507

CRP: C-reactive protein; IL-6: interleukin 6; MCP-1: monocyte chemoattractant protein-1